Mycobacterium bovis BCG as a delivery system for the RAP-1 antigen from Babesia bovis

Vaccine

Volumn 25, Issue 6, 2007, Pages 1104-1113

  Santangelo, M P ^a   McIntosh, D ^b   Bigi, F ^a   Armoa G R G ^b   Campos, A S D ^b   Ruybal, P ^a   Dellagostin, O A ^c   McFadden, J ^d   Mendum, T ^d   Gicquel, B ^e   Winter, N ^e   Farber, M ^a   Cataldi, A ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e INSTITUT PASTEUR   (France)

Author keywords

Babesia bovis; BCG; Heterologous

Indexed keywords

RECOMBINANT ANTIGEN; RHOPTRY ASSOCIATED PROTEIN 1;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BABESIA BOVIS; BABESIOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BABESIA BOVIS; BACTERIAL VACCINES; FEMALE; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; PROTOZOAN PROTEINS; VACCINES, COMBINED;

EID: 33845639682     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.069     Document Type: Article

References (51)

1. Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol 57 (1995) 19-41
2. Bock R., Jackson L., de Vos A., and Jorgensen W. Babesiosis of cattle. Parasitology 129 (2004) S247-S269
3. Brown W.C., and Palmer G.H. Designing blood stage vaccines against Babesia bovis and B. bigemina. Parasitol Today 15 (1999) 275-281
4. Jenkins M.C. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet Parasitol 101 (2001) 291-310
5. Norimine J., Mosqueda J., Suarez C., Palmer G.H., McElwain T.F., Mbassa G., et al. Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge. Infect Immun 71 (2003) 5021-5032
6. Goff W.L., Davis W.C., Palmer G.H., McElwain T.F., Johnson W.C., Bailey J.F., et al. Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies. Infect Immun 56 (1988) 2363-2368
7. Suarez C.E., Palmer G.H., Jasmer D.P., Hines S.A., Perryman L.E., and McElwain T.F. Characterization of the gene encoding a 60-kDa Babesia bovis merozoite protein with conserved and surface exposed epitopes. Mol Biochem Parasitol 46 (1991) 45-52
8. Suarez C.E., Palmer G.H., Hötzel I., and McElwain T.F. Structure, sequence, and transcriptional analysis of the Babesia bovis rap-1 multigene locus. Mol Biochem Parasitol 93 (1998) 215-224
9. Wright I.G., Casu R., Commins M.A., Dalrymple B.P., Gale K.R., Goodger B.V., et al. The development of a recombinant Babesia vaccine. Vet Parasitol 44 (1992) 3-13
10. Brown W.C., McElwain T.F., Ruef B.J., Suarez C.E., Shkap V., Chitko-McKown C.G., et al. Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains. Infect Immun 64 (1996) 3341-3350
11. Reduker D.W., Jasmer D.P., Goff W.L., Perryman L.E., Davis W.C., and McGuire T.C. A recombinant surface protein of Babesia bovis elicits bovine antibodies that react with live merozoites. Mol Biochem Parasitol 35 (1989) 239-247
12. Dalgliesh R.J. Babesiosis. Immunology and molecular biology of parasitic infections (1993), Blackwell, Oxford p. 352-83
13. Ohara N., and Yamada T. Recombinant BCG vaccines. Vaccine 19 (2001) 4089-4098
14. Winter N., Lagranderie M., Gangloff S., Leclerc C., Gheorghiu M., and Gicquel B. Recombinant BCG strains expressing the SIVmac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13 (1995) 471-478
15. Abdelhak S., Louzir H., Timm J., Blel L., Benlasfar Z., Lagranderie M., et al. Recombinant BCG expressing the Leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology 141 (1995) 1585-1592
16. Connell N.D., Medina-Acosta E., McMaster W.R., Bloom B.R., and Russell D.G. Effective immunization against cutaneous leishmaniasis with recombinant Bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci USA 90 (1993) 11473-11477
17. Matsumoto S., Yukitake H., Kanbara H., and Yamada T. Recombinant Mycobacterium bovis Bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 188 (1998) 845-854
18. Nascimento I.P., Dias W.O., Mazzantini R.P., Miyaji E.N., Gamberini M., Quintilio W., et al. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect Immun 68 (2000) 4877-4883
19. Stover C.K., de la Cruz V.F., Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., et al. New use of BCG for recombinant vaccines. Nature 351 6326 (1991) 456-482
20. Varaldo P.B., Leite L.C., Dias W.O., Miyaji E.N., Torres F.I., Gebara V.C., et al. Recombinant Mycobacterium bovis BCG Expressing the Sm14 Antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun 72 (2004) 3336-3343
21. Leung N.J., Aldovini A., Young R., Jarvis M.A., Smith J.M., Meyer D., et al. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env and Nef proteins. Virology 268 (2000) 94-103
22. Yasutomi Y., Koenig S., Haun S.S., Stover C.K., Jackson R.K., Conard P., et al. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 150 (1993) 3101-3107
23. Parish T., and Stoker N.G. Electroporation of mycobacteria. Mycobacteria protocols. Method in molecular biology 101 (1998), Humana Press Totowa, New Jersey 120-144
24. Anziani O.S., Guglielmone A.A., Abdala A.A., Aguirre D.H., and Mangold A.J. Protección conferida por Babesia bovis vacunal en novillos Holando Argentino. Rev Med Vet (Buenos Aires) 74 (1993) 47-49
25. Levi M.G., and Ristic M. Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science 207 (1980) 1218-1220
26. Le Dantec C., Winter N., Gicquel B., Vincent V., and Picardeau M. Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems. J Bacteriol 183 (2001) 2157-2164
27. Himmelrich H., Lo-Man R., Winter N., Guermonprez P., Sedlik C., Rojas M., et al. Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE. Vaccine 18 (2000) 2636-2647
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. Brown W.C., Logan K.S., Wagner G.G., and Tetzlaff C.L. Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites. Infect Immun 59 (1991) 2418-2426
30. Lee B.Y., Hefta S.A., and Brennan P.J. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun 60 (1992) 2066-2074
31. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., et al. Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med 178 (1993) 197-209
32. Grode L., Kursar M., Fensterle J., Kaufmann S.H., and Hess J. Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guérin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J Immunol 168 (2002) 1869-1876
33. Medeiros M., Armôa G.R., Dellagostin O.A., and McIntosh D. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin. Can J Microbiol 51 (2005) 1015-1020
34. Haeseleer F. Structural instability of recombinant plasmids in mycobacteria. Res Microbiol 145 (1994) 683-687
35. Al-Zarouni M., and Dale J.W. Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains. Tuberculosis 82 (2002) 283-291
36. Méderlé I., Bourguin I., Ensergueix D., Badell E., Moniz-Peireira J., Gicquel B., et al. Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect Immun 70 (2002) 303-314
37. Buddle B.M., Pollock J.M., Skinner M.A., and Wedlock D.N. Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens. Int J Parasitol 33 (2003) 555-566
38. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 (2002) 3026-3032
39. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., and Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 8 (2001) 571-578
40. Wards B.J., de Lisle G.W., and Collins D.M. An ESAT-6 knockout mutant of Mycobacterium bovis produced by homologous recombination will be useful for development of a live tuberculosis vaccine. Tubercle Lung Dis 80 (2000) 1985-1989
41. Van Pinxteren L.A., Ravn P., Agger E.M., Pollock J., and Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 7 (2000) 155-160
42. Abomoelak B., Huygen K., Kremer L., Turnee M., and Locht C. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein. Infect Immun 67 (1999) 5100-5105
43. Dellagostin O.A., Esposito G., Earles L.J., Dale J.W., and McFadden J.J. Activity of mycobacterial promoters during intracellular and extracellular growth. Microbiology 141 (1995) 1785-1792
44. Timm J., Lim E.M., and Gicquel B. Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM. J Bacteriol 176 (1994) 6749-6753
45. Jacques N., and Dreyfus M. Translation initiation in Escherichia coli: old and new questions. Mol Microbiol 4 7 (1990) 1063-1067
46. Yokoyama N., Suthisak B., Hirata H., Matsuo T., Inoue N., Sugimoto C., et al. Cellular localization of Babesia bovis merozoite rhoptry-associated protein 1 and its erythrocyte-binding activity. Infect Immun 70 (2002) 5822-5826
47. Norimine J., Suarez C.E., McElwain T.F., Florin-Christensen M., and Brown W.C. Immunodominant epitopes in Babesia bovis rhoptry-associated protein 1 that elicit memory CD4(+)-T-lymphocyte responses in B. bovis-immune individuals are located in the amino-terminal domain. Infect Immun 70 (2002) 2039-2048
48. Burlein J.E., Stover C.K., Offutt S., and Hanson M. Expression of foreign genes in mycobacteria. In: Bloom B.R. (Ed). Tuberculosis: pathogenesis, protection and control (1994), ASM Press, Washington, DC
49. Batoni G., Maisetta G., et al. Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium. FEMS Microb Lett 169 (1998) 117-124
50. Horwitz M.A., Harth G., Dillon B.J., and Maslesa-Galic S. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity. Vaccine 24 (2006) 443-451
51. Dennehy M., and Williamson A.L. Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23 (2005) 1209-1224